Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial.
Gohari S, Reshadmanesh T, Khodabandehloo H, Karbalaee-Hasani A, Ahangar H, Arsang-Jang S, Ismail-Beigi F, Dadashi M, Ghanbari S, Taheri H, Fathi M, Muhammadi MJ, Mahmoodian R, Asgari A, Tayaranian M, Moharrami M, Mahjani M, Ghobadian B, Chiti H, Gohari S. Gohari S, et al. Among authors: asgari a. Diabetol Metab Syndr. 2022 Nov 17;14(1):170. doi: 10.1186/s13098-022-00951-5. Diabetol Metab Syndr. 2022. PMID: 36397128 Free PMC article.
Efficacy of a standardized herbal formulation from Glycyrrhiza glabra L. as an adjuvant treatment in hospitalized patients with COVID-19: A Randomized Controlled trial.
Soleiman-Meigooni S, Hoseini Yekta N, Sheikhan HR, Aminianfar M, Hamidi-Farahani R, Ahmadi M, Asgari A, Kazemi-Galougahi MH, Rahimi R. Soleiman-Meigooni S, et al. Among authors: asgari a. J Ayurveda Integr Med. 2022 Oct-Dec;13(4):100670. doi: 10.1016/j.jaim.2022.100670. Epub 2022 Oct 28. J Ayurveda Integr Med. 2022. PMID: 36320214 Free PMC article.
Efficacy of Red Blood Cell Exchange as Adjunctive Treatment for Hypoxemia and Survival Rate of Patients With Severe Coronavirus-2 Disease: An Open-Labeled Phase 2 Randomized Clinical Trial.
Aminianfar M, Soleiman-Meigooni S, Hamidi-Farahani R, Darvishi M, Hoseini-Shokouh SJ, Asgari A, Faraji-Hormozi S, Asli M. Aminianfar M, et al. Among authors: asgari a. Front Med (Lausanne). 2022 Jul 8;9:899593. doi: 10.3389/fmed.2022.899593. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35872770 Free PMC article.
152 results